Position in BCYC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,093,515
-$8,462,969 QoQ
Shares Held
3,468,430
0.0% QoQ
Ownership
4.96%
of shares outstanding
% of Portfolio
2.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FCPM III SERVICES B.V. holds $714,925,124 across 9 Biotechnology names. BCYC ranks #9 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,198,900 | $294,456,788 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
4,644,386 | $84,202,718 | |
| 3 | VOR |
Vor Biopharma Inc.
|
4,117,354 | $73,453,595 | |
| 4 | ENGN |
enGene Therapeutics Inc.
|
9,632,561 | $65,597,740 | |
| 5 | MPLT |
MapLight Therapeutics, Inc.
|
3,226,400 | $65,592,712 | |
| 6 | DMRA |
Damora Therapeutics, Inc.
|
2,441,000 | $63,221,900 | |
| 7 | CBIO |
Crescent Biopharma, Inc.
|
1,677,852 | $30,822,141 | |
| 8 | REPL |
Replimune Group, Inc.
|
2,808,368 | $21,484,015 |
All Filings in BCYC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,093,515 | 3,468,430 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,556,484 | 3,468,430 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,721,034 | 3,452,330 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $23,993,693 | 3,452,330 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,310,281 | 3,452,330 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $48,332,620 | 3,452,330 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $52,953,317 | 2,339,961 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $42,967,334 | 2,122,892 | Shares | Defined | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||